Lupine appoints Abdelaziz Toumi as CEO of newly established HR News division, ETHRWorld

New Delhi pharma major Lupine Ltd on Monday announced the appointment of Abdelaziz Toumi as CEO of its newly established subsidiary Lupine Manufacturing Solutions. Toumi is an experienced leader combining scientific and commercial skills, with over two decades of experience in the biotechnology, pharmaceutical and CDMO sectors spanning Europe, North America and Asia, Lupine said in its regulatory filing. He held management positions at Bayer, Merck, Catalent, Lonza and KBI Biopharma. He added that he will be living in Switzerland and will spend a lot of time in India.

Lupine Manufacturing Solutions (LMS) develops, manufactures and sells active pharmaceutical ingredients and is beginning to expand its contract development and manufacturing (CDMO) business.

“He brings a wealth of knowledge and experience in the API and CDMO space and will play a key role in establishing LMS as a trusted and preferred partner for our customers around the world,” said Lupine Managing Director Nilesh Gupta.

Toumi holds a PhD in chemical engineering and a master’s degree in business administration from the University of Southern Queensland, records show.